Month: September 2021
Plinabulin in combination with G-CSF is undergoing regulatory review for potential approval in the U.S. and China for the prevention of CIN, with a U.S. PDUFA date of November 30, 2021.
NEW YORK, Sept. 16, 2021 (GLOBE NEWSWIRE) — BeyondSpring Pharmaceuticals (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global pharmaceutical company focused on the development of innovative cancer therapeutics, today announced new positive data on plinabulin from its chemotherapy-induced neutropenia (CIN) prevention program with three poster presentations at the European Society for Medical Oncology (ESMO) 2021 Congress taking place from September 16-21, 2021. Plinabulin, the Company’s first-in-class lead asset, in combination with G-CSF for the prevention of chemotherapy-induced neutropenia (CIN) is currently under U.S. and China regulatory...
VivoPower International PLC wins international TMA award
Written by Customer Service on . Posted in Public Companies.
Award is for hyper–turnaround of VivoPower, completed in only 7 months
Hyper–turnaround was led by Kevin Chin, founder of Arowana
LONDON, Sept. 16, 2021 (GLOBE NEWSWIRE) — VivoPower International PLC (“VivoPower”) is pleased to announce that the company has been recognised as one of the global winners of the 2021 Turnaround Management Association (TMA) Transaction of the Year Awards. The honour is in recognition of the hyper-turnaround of VivoPower in 2020 and is for the small companies (sub-US$50m revenue) category.
Since 1993, TMA has honoured excellence through its annual awards program, which recognises the most successful turnarounds and impactful transactions internationally. Awardees are chosen through a rigorous peer-review process by the volunteer TMA Awards Committee. The process includes extensive diligence...
Autolus Therapeutics provides an update on its manufacturing facility in Stevenage, UK
Written by Customer Service on . Posted in Public Companies.
– Allowing global commercial launch capacity for obe-cel (AUTO1)
LONDON, Sept. 16, 2021 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that planning approval has been granted to build the Company’s new manufacturing facility in Stevenage, UK. The 70,000 square foot facility is being built by Merit Holdings Limited as general contractor for the Reef Group, who will lease the facility to Autolus. Global commercial launch capacity for obecabtagene autoleucel (obe-cel) will initially be provided by the existing clinical trial manufacturing facility at The Cell and Gene Therapy Catapult (CGTC) facility, and will then move to the new Autolus facility which will allow for GMP capacity for approximately...
GZ6G Technologies Hires Daniela Bittner as Director of Government Procurement
Written by Customer Service on . Posted in Public Companies.
Accelerating Government Capabilities with Touchless Technologies in 2022
LAS VEGAS, NV, Sept. 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – GZ6G Technologies (OTCMARKETS: GZIC), the complete enterprise smart solutions provider for large venues and cities, today announced the appointment of Daniela Bittner as Director of Government Procurement. In this position, Daniela will be responsible for implementing and building a team to streamline enterprise contract acquisitions, manage subcontractor agreements, oversee management policies, and simplify product purchase opportunities for government partnerships. Her historical leadership experience, knowledge, success and support will have an immediate impact on GZ6G Technologies enterprise and Government revenue acquisitions.
GZ6G Technologies Corp. is a smart solutions technology company...
QIWI Completes the Sale of its stake in Tochka Project
Written by Customer Service on . Posted in Public Companies.
NICOSIA, Cyprus, Sept. 16, 2021 (GLOBE NEWSWIRE) — QIWI plc (NASDAQ: QIWI) (MOEX: QIWI) (“QIWI” or the “Company”), a leading provider of next generation payment and financial services in Russia and the CIS, today announced that it has completed the sale of its stake in JSC Tochka (“Tochka”) to Bank Otkritie Financial Corporation PJSC (“Otkritie Bank”).
QIWI sold its 40% stake in the capital of Tochka for RUB 4.95 billion. The valuation was based on the current enterprise value of RUB 11.0 billion. Under the terms of sale certain performance adjustments may occur in 2Q 2022 depending on Tochka’s FY 2021 audited results. We believe that such price adjustments may increase the deal value.
The transaction has been approved by QIWI’s Board of Directors in July 2021. Russia’s Federal Antimonopoly Service announced...
ION receives grant to support UK net zero target through port decarbonization
Written by Customer Service on . Posted in Public Companies.
HOUSTON, Sept. 16, 2021 (GLOBE NEWSWIRE) — ION Geophysical Corporation’s Edinburgh-based Software group today announced the Company received a grant to advance port decarbonization through its climate-smart platform, Marlin SmartPort™. The grant supports the UK’s Ten Point Plan to address climate change and help achieve the country’s net-zero emissions target by 2050. The Data-Led Emissions Management (D-LEMA) project is part of the Clean Maritime Demonstration Competition, funded by the UK Department for Transport and delivered in partnership with Innovate UK. The 6-month pilot study will validate whether vessel fuel usage and carbon dioxide emissions can be reliably estimated in and around ports using the International Maritime Organization (IMO) global standard.
Announced in March 2020, and part of the Prime Minister’s Ten Point...
CW Petroleum Corp (CWPE): Reports 2021 First Six-Months Revenue of $4.2 Million Versus $3.4 Million in 2020 for a 21% Growth
Written by Customer Service on . Posted in Public Companies.
Katy, TX, Sept. 16, 2021 (GLOBE NEWSWIRE) — CW Petroleum Corp (OTCQB: CWPE), a leading provider of Proprietary No-Ethanol Fuels and Biofuel, has reported its six-month year-to-date financial results ending June 30, 2021. At the close of the second quarter, gross sales reached approximately $4.2 million against $3.4 million reported in the first six months of 2020, for a 21-percent increase.
Chris Williams, Chief Executive Officer of CW Petroleum Corp, shared, “We are encouraged by the results announced today that continue to show an upward trajectory in the growth and robust financial health of our company. We remain working alongside a Global Investment Bank to raise capital to expand our footprint throughout new markets in the United States and work towards our ultimate goal of qualifying for the NASDAQ.”
Chris Williams added,...
Media Advisory: TC Energy to divest remaining 15 per cent interest in Northern Courier Pipeline
Written by Customer Service on . Posted in Public Companies.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
CALGARY, Alberta, Sept. 16, 2021 (GLOBE NEWSWIRE) — Media Advisory – TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) announced today that Astisiy Limited Partnership, comprised of Suncor and eight Indigenous communities in the Regional Municipality of Wood Buffalo (RMWB), will acquire TC Energy’s remaining 15 per cent equity interest in the Northern Courier Pipeline (NCP).
“We are pleased that Indigenous communities will be provided the opportunity to participate in and benefit from the ownership of this asset, through Suncor exercising its previously-acquired right to purchase our minority interest,” said Bevin Wirzba, TC Energy’s Executive Vice-President, Strategy and Corporate Development and President, Liquids Pipelines.
“At...
ALX Oncology Announces Initiation of Investigator-Sponsored Trial of Evorpacept (ALX148) in Patients with Indolent and Aggressive Non-Hodgkin Lymphoma
Written by Customer Service on . Posted in Public Companies.
— Phase 1/2 study conducted at The University of Texas M.D. Anderson Cancer Center
BURLINGAME, Calif., Sept. 16, 2021 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today announced the initiation of a Phase 1/2 investigator-sponsored trial of evorpacept (also known as ALX148), a next generation CD47 blocker, in combination with rituximab and lenalidomide for the treatment of patients with indolent and aggressive non-Hodgkin lymphoma (“NHL”). This study is being led by Dr. Paolo Strati at The University of Texas M.D. Anderson Cancer Center (“MDACC”), one of the largest multidisciplinary programs in the U.S. for treating NHL.
“We are excited to launch this study that builds upon the promising...
GXO Announces Elizabeth Fogarty as Chief Communications Officer
Written by Customer Service on . Posted in Public Companies.
GREENWICH, Conn., Sept. 16, 2021 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, today announced that Elizabeth Fogarty has joined the company as its new Chief Communications Officer. Elizabeth joins GXO from Citigroup Inc. where she served as Managing Director and Head of Communications for the Global Consumer Bank. She will be responsible for managing GXO’s global external and internal communications.
Elizabeth is a communications leader with more than two decades of experience, including 17 years at Citi. Most recently, she managed media relations, reputation management and employee communications for Citi’s Global Consumer Bank, a leader in retail banking, wealth management and credit cards, serving more than 100 million clients across 19 markets.
“Elizabeth brings...
